Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Effectiveness of Intradermal Trivalent Influenza Vaccine With Topical Imiquimod, a Double Blind Randomized Controlled Trial

NCT01508884 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT01508884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01508884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Effectiveness of Intradermal Trivalent Influenza Vaccine With Topical Imiquimod, a Double Blind Randomized Controlled Trial
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
December 31, 2012
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic illness